4//SEC Filing
Rasmussen Thomas K 4
Accession 0001235802-11-000125
CIK 0001114200other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 3:06 PM ET
Size
29.0 KB
Accession
0001235802-11-000125
Insider Transaction Report
Form 4
Rasmussen Thomas K
VP Mtka Op & Global Sup. Chain
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-06-17−25,000→ 25,000 totalExercise: $10.82Exp: 2016-02-09→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−24,750→ 0 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (24,750 underlying) - Disposition to Issuer
Common Stock
2011-06-17−11,276.558→ 4,888 total - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−25,000→ 0 totalExercise: $10.82Exp: 2016-02-09→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−30,380→ 0 totalExercise: $20.05Exp: 2018-02-10→ Common Stock (30,380 underlying) - Disposition to Issuer
Common Stock
2011-06-17−4,888→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−87,500→ 12,500 totalExercise: $19.55Exp: 2014-08-19→ Common Stock (87,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−8,250→ 24,750 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (8,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−5,000→ 0 totalExercise: $14.36Exp: 2015-03-05→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−12,500→ 0 totalExercise: $19.55Exp: 2014-08-09→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−15,000→ 5,000 totalExercise: $14.36Exp: 2015-03-05→ Common Stock (15,000 underlying)
Footnotes (11)
- [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $338,296.74 in cash.
- [F10]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 18,698 shares of Endo common stock with an exercise price of $24.44 per share.
- [F11]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 22,952 shares of Endo common stock with an exercise price of $26.54 per share.
- [F2]These restricted shares were assumed by Endo in the Merger in exchange for 3,692 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
- [F3]This option, which vested with respect to 25% of the shares on September 30, 2008 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 87,500 shares in the Merger in exchange for a cash payment of $913,937.50 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F4]This option, which vested with respect to 25% of the shares on September 30, 2008 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 9,443 shares of Endo common stock with an exercise price of $25.89 per share.
- [F5]This option, which vested with respect to 25% of the shares on March 31, 2009 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 15,000 shares in the Merger in exchange for a cash payment of $234,675 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F6]This option, which vested with respect to 25% of the shares on March 31, 2009 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 3,777 shares of Endo common stock with an exercise price of $19.01 per share.
- [F7]This option, which vested with respect to 25% of the shares on March 31, 2010 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 25,000 shares in the Merger in exchange for a cash payment of $479,375 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F8]This option, which vested with respect to 25% of the shares on March 31, 2010 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 18,887 shares of Endo common stock with an exercise price of $14.33 per share.
- [F9]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 8,250 shares in the Merger in exchange for a cash payment of $95,205 representing the difference between the exercise price of the option and the $30.00 per share price.
Documents
Issuer
AMERICAN MEDICAL SYSTEMS HOLDINGS INC
CIK 0001114200
Entity typeother
Related Parties
1- filerCIK 0001469660
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 3:06 PM ET
- Size
- 29.0 KB